CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 97 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $223,000 | -60.5% | 44,710 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $565,000 | +33.9% | 44,710 | +4.1% | 0.00% | 0.0% |
Q3 2020 | $422,000 | +0.5% | 42,951 | +1.8% | 0.00% | 0.0% |
Q2 2020 | $420,000 | +16.7% | 42,183 | +3.7% | 0.00% | 0.0% |
Q1 2020 | $360,000 | +16.5% | 40,693 | +21.6% | 0.00% | 0.0% |
Q4 2019 | $309,000 | +56.9% | 33,455 | 0.0% | 0.00% | – |
Q3 2019 | $197,000 | -50.9% | 33,455 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $401,000 | -0.7% | 33,455 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $404,000 | -1.2% | 33,455 | +2.7% | 0.00% | 0.0% |
Q4 2018 | $409,000 | -15.5% | 32,585 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $484,000 | -11.7% | 32,585 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $548,000 | -11.9% | 32,585 | +20.0% | 0.00% | 0.0% |
Q1 2018 | $622,000 | -14.9% | 27,150 | -3.9% | 0.00% | -50.0% |
Q4 2017 | $731,000 | +74.0% | 28,249 | -0.8% | 0.00% | +100.0% |
Q3 2017 | $420,000 | -5.2% | 28,469 | -10.4% | 0.00% | 0.0% |
Q2 2017 | $443,000 | -20.0% | 31,770 | -2.2% | 0.00% | 0.0% |
Q1 2017 | $554,000 | +58.3% | 32,470 | -4.4% | 0.00% | 0.0% |
Q4 2016 | $350,000 | -0.8% | 33,970 | -2.6% | 0.00% | 0.0% |
Q3 2016 | $353,000 | -9.0% | 34,870 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $388,000 | -12.8% | 34,570 | +6.1% | 0.00% | 0.0% |
Q1 2016 | $445,000 | -17.6% | 32,590 | +14.4% | 0.00% | 0.0% |
Q4 2015 | $540,000 | +2.9% | 28,491 | +1.8% | 0.00% | 0.0% |
Q3 2015 | $525,000 | +25.6% | 27,990 | -0.4% | 0.00% | 0.0% |
Q2 2015 | $418,000 | +156.4% | 28,090 | +132.1% | 0.00% | – |
Q1 2014 | $163,000 | – | 12,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
L1 Capital Pty Ltd | 968,198 | $9,634,000 | 3.29% |
INGALLS & SNYDER LLC | 1,382,048 | $13,751,000 | 0.79% |
SPHERA FUNDS MANAGEMENT LTD. | 700,710 | $6,972,000 | 0.66% |
Alambic Investment Management, L.P. | 17,900 | $178,000 | 0.45% |
RA Capital Management | 1,858,474 | $18,492,000 | 0.36% |
Perceptive Advisors | 2,150,641 | $21,398,000 | 0.35% |
Eversept Partners, LP | 232,983 | $2,318,181 | 0.32% |
GSA CAPITAL PARTNERS LLP | 17,351 | $173,000 | 0.10% |
Alyeska Investment Group, L.P. | 502,783 | $5,003,000 | 0.08% |
KENNEDY CAPITAL MANAGEMENT LLC | 263,958 | $2,626,000 | 0.08% |